project id: TCGA-LGG; case submitter id: TCGA-VW-A7QS; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.38; rna integrity number: 8.1; age at index: 35; days to birth: -12820; ethnicity: not hispanic or latino; gender: female; race: asian; vital status: Alive; year of birth: 1976; age at diagnosis: 12820; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 706.0; icd 10 code: C71.0; last known disease status: not reported; morphology: 9451/3; primary diagnosis: Oligodendroglioma, anaplastic; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cerebrum; synchronous malignancy: No; tissue or organ of origin: Cerebrum; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 805; initial weight: 260.0; sample id: aa7bd44d-53de-4f4a-8a4b-7cd16026279b; sample submitter id: TCGA-VW-A7QS-01A; portion id: d25bdfed-5ceb-4f34-9d3d-549b8260c1ef; portion submitter id: TCGA-VW-A7QS-01A-12; slide id: a84e22d0-aba4-43ee-97ce-7340746a0dba; slide submitter id: TCGA-VW-A7QS-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 90.0; section location: TOP;